Armodafinil for Treatment of Excessive Sleepiness Associated With Shift Work Disorder: A Randomized Controlled Study

Czeisler, Charles A.; Walsh, James K.; Wesnes, Keith A.; Arora, Sanjay; Roth, Thomas
November 2009
Mayo Clinic Proceedings;Nov2009, Vol. 84 Issue 11, p958
Academic Journal
OBJECTIVE: To assess the effect of armodafinil, 150 mg, on the physiologic propensity for sleep and cognitive performance during usual night shift hours In patients with excessive sleepiness associated with chronic (≥3 months) shift work disorder (SWD) of moderate or greater severity. PATIENTS AND METHODS: This 12-week, randomized controlled study was conducted at 42 sleep research facilities in North America from April 2 through December 23, 2004, and enrolled 254 permanent or rotating night shift workers with SWD. Entry criteria included excessive sleepiness during usual night shifts for 3 months or longer (corroborated by mean sleep latency of Ȧ6 minutes on a Multiple Sleep Latency Test), insomnia (sleep efficiency ≤87.5% during daytime sleep), and SWD that was judged clinically to be of moderate or greater severity. Patients received armodafinil, 150 mg, or placebo 30 to 60 minutes before each night shift. Physiologic sleep propensity during night shift hours, clinical impression of severity, patient-reported sleepiness, and cognitive function were assessed during laboratory night shifts at weeks 4, 8, and 12. RESULTS: Armodafinil significantly improved mean (SD) sleep latency from 2.3 (1.6) minutes at baseline to 5.3 (5.0) minutes at final visit, compared with a change from 2.4 (1.6) minutes to 2.8 (2.9) minutes in the placebo group (P<.001). Clinical condition ratings improved in more patients receiving armodafinil (79%) vs placebo (59%) (P=.001). As reported by patients' diaries, armodafinil significantly reduced sleepiness during laboratory nights (P<.001), night shifts at work (P<.001), and the commute home (P=.003). Armodafinil improved performance on standardized memory (P<.001) and attention (power, P=.001; continuity, P<.001) tests compared with placebo. Armodafinil was well tolerated and did not affect daytime sleep, as measured by polysomnography. CONCLUSION: In patients with excessive sleepiness associated with chronic SWD of moderate or greater severity, armodafinil significantly improved wakefulness during scheduled night work, raising mean nighttime sleep latency above the level considered to indicate severe sleepiness during the daytime. Armodafinil also significantly improved measures of overall clinical condition, long- term memory, and attention.


Related Articles

  • Under the Influence of Drowsiness. RIHA, RENATA L. // Sleep Review;Jun2009, Vol. 10 Issue 5, p16 

    The article describes the case of a 17-year-old male who crashed his car because of falling asleep at the wheel. Upon questioning, he was found suffering from excessive daytime sleepiness (EDS) since the age of 14, and would fall asleep during class or even standing up. After an overnight...

  • Ambulatory titration of continuous positive airway pressure was as effective as polysomnography for obstructive sleep apnoea.  // Evidence Based Medicine;Oct2007, Vol. 12 Issue 5, p148 

    The article presents the author's view on the study "Diagnosis and initial management of obstructive sleep apnea without polysomnography: a randomized validation study." The author assert that in this study, the symptoms are only loosely correlated with the diagnosis and severity of apnoea and...

  • Drug-induced sleep endoscopy: a two drug comparison and simultaneous polysomnography. Carrasco Llatas, Marina; Agostini Porras, Gabriela; Cuesta González, Maria; Rodrigo Sanbartolomé, Adelaida; Giner Bayarri, Pau; Gómez-Pajares, Fernando; Dalmau Galofre, José // European Archives of Oto-Rhino-Laryngology;Jan2014, Vol. 271 Issue 1, p181 

    The purpose of the present study was to compare pharyngeal and polysomnographical findings during drug-induced sleep endoscopy (DISE) performed with either propofol or midazolam as a single sedative agent. It is prospective, non-randomized, double-blinded case series study. Sixteen patients with...

  • Differences between day and nonday workers in exposure to physical and psychosocial work factors in the Danish eldercare sector. Nabe-Nielsen, Kirsten; T�chsen, Finn; Christensen, Karl Bang; Garde, Anne Helene; Diderichsen, Finn // Scandinavian Journal of Work, Environment & Health;Jan2009, Vol. 35 Issue 1, p48 

    The article presents a study which examined the exposure to physical and psychosocial work factors of day and nonday female workers in the Danish eldercare sector. Results show that while fixed nonday workers were more exposed to low job control, physical and psychological violence, decreased...

  • Actigraphic assessment of sleep in chronic obstructive pulmonary disease. Nunes, Deuzilane; Bruin, Veralice; Louzada, Fernando; Peixoto, Carina; Cavalcante, Antônio; Castro-Silva, Cláudia; Bruin, Pedro // Sleep & Breathing;Mar2013, Vol. 17 Issue 1, p125 

    Purpose: Previously, sleep in chronic obstructive pulmonary disease (COPD) has been objectively investigated only by lab-based polysomnography. The main purpose of this study was to evaluate sleep quality in COPD patients in their home environment using actigraphy. We also investigated the...

  • Daytime polysomnography for early diagnosis and treatment of patients with suspected sleep-disordered breathing. Seiko Miyata; Akiko Noda; Seiichi Nakata; Hidehito Yagi; Eriko Yanagi; Kumiko Honda; Tatsuki Sugiura; Shigeru Nakai; Tsutomu Nakashima; Yasuo Koike // Sleep & Breathing;Jun2007, Vol. 11 Issue 2, p109 

    Abstract  Excessive daytime sleepiness (EDS) is a common complaint among patients with sleep-disordered breathing (SDB). Population-based studies on traffic and industrial accidents suggest a relationship between EDS and life-threatening events, and adults with EDS have cognitive and...

  • Validation and modification of the Epworth Sleepiness Scale in Peruvian population. Rosales-Mayor, Edmundo; Rey de Castro, Jorge; Huayanay, Leandro; Zagaceta, Kenny // Sleep & Breathing;Feb2012, Vol. 16 Issue 1, p59 

    Purpose: The main purpose of this study was to develop a cross-cultural adaptation of the Epworth Sleepiness Scale for Peruvian population (ESS-VP) and to provide evidence of reliability and validity to this scale. We also modified the ESS-VP for non-driving Peruvian population (ESS-MPV)....

  • Narcolepsy mistaken for epilepsy. Zeman, Adam; Douglas, Neil; Aylward, Rebecca // BMJ: British Medical Journal (International Edition);01/27/2001, Vol. 322 Issue 7280, p216 

    Examines narcolepsy, a distinctive yet underdiagnosed disorder of sleep and waking. Risk factors associated with the disorder, including excessive daytime sleepiness, cataplexy, and hypnagogis hallucinations; How narcolepsy is often misdiagnosed as epilepsy; History of the disorder.

  • Recognition and diagnosis of sleep disorders in Parkinson's disease. Louter, Maartje; Aarden, Willemijn; Lion, Joy; Bloem, Bastiaan; Overeem, Sebastiaan // Journal of Neurology;Oct2012, Vol. 259 Issue 10, p2031 

    Sleep disturbances are among the most frequent and incapacitating non-motor symptoms of Parkinson's disease (PD), and are increasingly recognized as an important determinant of impaired quality of life. Here we review several recent developments regarding the recognition and diagnosis of sleep...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics